Veeda Clinical Research Pvt Ltd
We are one of the largest Independent CROs in India with a scientific edge, technical skills and better foresight for BA BE Studies & Clinical trials; with an objective of becoming a catalyst for enhanced drug developments to facilitate better patient treatments.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.
Uniphar
Uniphar Group is a trusted global partner to pharmaceutical, medtech, and supply chain and retail companies, working to improve patient access to medicines around the world.
Company Details
Latest Content from PMHub
Case Study: Understanding the patient journey and addiction treatment pathways
White Papers and Resources | November 23, 2016 | Inizio
Our client had previously conducted some research and knew that a large proportion of target patients also had addiction issues. They wanted to know more about addiction treatment pathways and...
Research Partnership has published a new Living with Chronic Pain market report for 2016
White Papers and Resources | November 23, 2016 | Inizio
Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients...
Nutraceuticals: Rich in Potential
White Papers and Resources | November 23, 2016 | Inizio
Published in eyeforpharma October 2016 by Marc Yates
Case Study: Qualitative research with payers in low and middle income countries
White Papers and Resources | November 23, 2016 | Inizio
Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...
Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers
White Papers and Resources | November 23, 2016 | Inizio
In association with PMGroup
Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community
White Papers and Resources | November 23, 2016 | Inizio
Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited. In order to help increase uptake, they wanted to publish the market research findings...
Towards a culture of evaluation and evidence-based decision making in global health
White Papers and Resources | November 23, 2016 | Inizio
Reflections on THET Conference 2016: Evidence, Effectiveness & Impact
Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016
White Papers and Resources | November 23, 2016 | Inizio
Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...
The Internet of Things
White Papers and Resources | November 23, 2016 | Inizio
Evolution from man to machine
Therapy Watch expands its oncology portfolio
White Papers and Resources | November 23, 2016 | Inizio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio...